Anhui Anke Bio-engineering (Group) Co., Ltd. announces its subsidiary Shanghai Suhao Yiming Pharmaceutical Co., Ltd. has received a CEP certificate from the European Directorate for the Quality of Medicines & HealthCare for its Octreotide API. This certification grants market access to the EU, positively impacting the company's overseas expansion of peptide APIs.
Summary generated by AI · Always verify with source document
Stock Code: 300009 Stock Abbreviation: Anke Bio Announcement No.: 2026-035
Anhui Anke Bio-engineering (Group) Co., Ltd.
Announcement on Obtaining EU CEP Certificate for Octreotide API
The Company and all members of the Board of Directors guarantee the content of this announcement is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.